Cargando...

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

The application of DNA technology to regulate the transcription of disease-related genes in vivo has important therapeutic potentials. The transcription factor E2F plays a pivotal role in the coordinated transactivation of cell cycle-regulatory genes such as c-myc, cdc2, and the gene encoding prolif...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Morishita, R, Gibbons, G H, Horiuchi, M, Ellison, K E, Nakama, M, Zhang, L, Kaneda, Y, Ogihara, T, Dzau, V J
Formato: Artigo
Idioma:Inglês
Publicado: 1995
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC41600/
https://ncbi.nlm.nih.gov/pubmed/7597041
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!